Preferred Label : estradiol;
MeSH definition : The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at
3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian
estrogenic steroids.;
MeSH synonym : estradiol-17 beta; 17 beta-oestradiol; estradiol 17beta; Oestradiol; 17 beta-estradiol; 17 beta estradiol; estradiol 17 beta; 17 beta oestradiol; estradiol-17beta; Estradiol Anhydrous;
CISMeF synonym : orion brand of estradiol; estradiol orion brand; novartis pharmaceuticals brand of estradiol;
MeSH hyponym : estraderm TTS; estradiol, sodium salt; ovocyclin; estrace; estradiol, monosodium salt; estradiol, (-)-Isomer; vivelle; estradiol hemihydrate, (17 alpha)-Isomer; aerodiol; Estradiol Valeriante; Progynon Depot;
Related MeSH term : estradiol, (8 alpha,17 beta)-Isomer; estradiol, (9 beta,17 alpha)-Isomer; estradiol, (8 alpha,17 beta)-( -)-Isomer; estradiol, (16 alpha,17 beta)-Isomer; estradiol hemihydrate; estradiol monohydrate; estradiol, ( -)-Isomer; estradiol, (16 alpha,17 alpha)-Isomer; Estradiol-17 alpha; estradiol, (9 beta,17 beta)-Isomer; Estradiol 17 alpha; Estradiol, (17-alpha)-Isomer;
MeSH CAS label : Estra-1,3,5(10)-triene-3,17-diol (17beta)-;
MeSH Related Number : estradiol, (16 alpha,17 alpha)-Isomer; estradiol, (16 alpha,17 beta)-Isomer; estradiol, (8 alpha,17 beta)-( -)-Isomer; estradiol, (9 beta,17 alpha)-Isomer; estradiol, monosodium salt; estradiol, sodium salt; estradiol, (9 beta,17 beta)-Isomer; estradiol hemihydrate; estradiol, (8 alpha,17 beta)-Isomer; estradiol hemihydrate, (17 alpha)-Isomer; estradiol monohydrate; estradiol, ( -)-Isomer; estradiol, (-)-Isomer; 35380-71-3 (Estradiol hemihydrate); 50-28-2 (Estradiol); 15399-28-7; 17181-19-0; 17916-67-5; 18290-08-9; 19518-62-8; 19669-82-0; 3736-22-9; 517-04-4; 5864-38-0; 6045-52-9; 63667-07-2; 95463-67-5; CXY7B3Q98Z; 979-32-8 (estradiol valerate); OKG364O896;
Registry Number MeSH : 50-28-2;
Related CAS MeSH : 5864-38-0 (Estradiol, (9 beta,17 beta)-Isomer); 517-04-4 (Estradiol, (8 alpha,17 beta)-Isomer); 6045-52-9 (Estradiol hemihydrate, (17 alpha)-Isomer); 63667-07-2 (Estradiol monohydrate); 17916-67-5 (Estradiol, ( -)-Isomer); 3736-22-9 (Estradiol, (-)-Isomer); 19518-62-8 (Estradiol, (16 alpha,17 alpha)-Isomer); 18290-08-9 (Estradiol, (16 alpha,17 beta)-Isomer); 19669-82-0 (Estradiol, (8 alpha,17 beta)-( -)-Isomer); 95463-67-5 (Estradiol, (9 beta,17 alpha)-Isomer); 17181-19-0 (Estradiol, monosodium salt); 15399-28-7 (Estradiol, sodium salt); CXY7B3Q98Z (Estradiol hemihydrate);
MeSH annotation : for /antag also consider: ESTROGEN RECEPTOR MODULATORS; ESTROGEN RECEPTOR ANTAGONISTS;
and AROMATASE INHIBITORS.;
Wikipedia link : https://en.wikipedia.org/wiki/Estradiol;
Codes EINECS : 200-023-8;
Is substance : O;
UNII : 4TI98Z838E;
InChIKey : VOXZDWNPVJITMN-ZBRFXRBCSA-N;
Origin ID : D004958;
UMLS CUI : C0014912;
ATC code(s)
- ATC code(s)
- Allowable qualifiers
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- Indexing information
- MeSH indexing information
- Pharmacological action(s)
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- 11-fluoro-7-(5-(methyl(7,7,8,8,9,9,10,10,10-nonafluorodecyl)amino)pentyl)estra-1,3,5(10)-triene-3,17-diol [MeSH Supplementary Concept]
- EBCO [MeSH Supplementary Concept]
- EM 139 [MeSH Supplementary Concept]
- EM-1745 [MeSH Supplementary Concept]
- EM-1913 [MeSH Supplementary Concept]
- KW 2581 [MeSH Supplementary Concept]
- LE(2) [MeSH Supplementary Concept]
- TS 108 [MeSH Supplementary Concept]
- ZK253 [MeSH Supplementary Concept]
- ZK703 [MeSH Supplementary Concept]
- ZYC 5 [MeSH Supplementary Concept]
- divina [MeSH Supplementary Concept]
- implix [MeSH Supplementary Concept]
- lunelle [MeSH Supplementary Concept]
- netagen [MeSH Supplementary Concept]
- revalor [MeSH Supplementary Concept]
- Related MeSH term(s)
- See also
- Semantic type(s)
- UMLS correspondences (same concept)
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at
3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian
estrogenic steroids.
https://www.ema.europa.eu/en/medicines/human/EPAR/ryeqo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
relugolix
relugolix
drug approval
europe
endometriosis
estradiol
estradiol
relugolix, estradiol and norethisterone
Norethindrone Acetate
Norethindrone Acetate
fibroid uterus
administration, oral
risk management
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
---
https://www.has-sante.fr/jcms/p_3341327/fr/ryeqo-relugolix/-norethisterone/-estradiol-fibromes-uterins
2022
false
false
false
France
evaluation of the transparency committee
estradiol
fibromyoma uterus
Fibroma
leiomyoma, nos
fibroid uterus
registries
leiomyoma
estradiol
---
http://www.theses.fr/2019LYSE1101
2019
France
dissertations, academic
Stress
Animal
functional disorder, nos
oxidation
stress, nos
role
Animal
sleep apnea, nos
Hypertension
estradiol
sleep apnea syndromes
animal, nos
hypertensive disease, nos
models, animal
panthera uncia
oxidative stress
Endothelial dysfunction
sleep
Animal
absence of stress
estradiol
Animal
Animal
hypertension
Animal
Animal
Stress
apnea
---
Estradiol and testicular cancer
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/infovigilance-produits-sante-octobre-2019.html#a3.1
2019
false
false
false
Canada
French
English
case reports
drug information
estradiol
testicular neoplasms
transsexualism
Transgender Persons
feminization
---
https://ansm.sante.fr/actualites/cremes-contenant-de-lestradiol-a-dosage-eleve-retour-dinformation-sur-le-prac-doctobre-2019
2019
false
false
false
France
French
administration, topical
estradiol
estradiol
vaginal diseases
atrophy
---
https://www.has-sante.fr/portail/jcms/c_2867425/fr/fulvestrant-teva
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
fulvestrant
estradiol
Fulvestrant
---
https://www.has-sante.fr/portail/jcms/c_2779827/fr/estrotep-fluoroestradiol-18f-radiopharmaceutique-a-usage-diagnostique
https://www.has-sante.fr/portail/jcms/c_2779827/fr/estrotep
2017
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
radiopharmaceuticals
18-fluoro-17-estradiol
18-fluoro-17-estradiol
fluoroestradiol (18F)
breast neoplasms
neoplasm metastasis
Positron-Emission tomography
adult
neoplasms, hormone-dependent
Oestrogen receptor positive breast cancer
injections, intravenous
estradiol
estradiol
estradiol
---
https://www.has-sante.fr/portail/jcms/c_2806292/fr/divina-duova
2017
false
false
false
France
French
evaluation of the transparency committee
divina
drug combinations
estradiol
medroxyprogesterone
---
http://www.prescrire.org/Fr/3/31/52656/0/NewsDetails.aspx
2017
false
false
false
France
French
french abstract
borderline
menopause, nos
marginal
estradiol
ring
vaginal rings
menopause
contraceptive devices, female
medical futility
vagina, nos
estradiol
---
FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated
Estradiol Levels
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/60590a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
estradiol
breast neoplasms
antineoplastic agents, hormonal
breast neoplasms
menopause
radioimmunoassay
false positive reactions
fulvestrant
Fulvestrant
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60535331
2016
false
false
false
France
French
summary of product characteristics
package leaflet
administration, intravaginal
atrophic vaginitis
estradiol hemihydrate
Estradiol Hemihydrate
estradiol
---
http://www.has-sante.fr/portail/jcms/c_2627645/fr/activelle-kliogest-novofemme-trisequens
http://www.has-sante.fr/portail/jcms/c_1048378/activelle-kliogest-novofemme-trisequens
http://www.has-sante.fr/portail/jcms/c_544823/fr/activelle-/-kliogest-/-novofemme-/-trisequens
2016
false
France
French
Trisequens
progesterone congeners
estradiol, norethindrone drug combination
administration, oral
drug combinations
norethindrone
estradiol
norethisterone and estrogen
estrogens
norethisterone and estrogen
insurance, health, reimbursement
estrogen replacement therapy
osteoporosis, postmenopausal
treatment outcome
evaluation of the transparency committee
Norethindrone Acetate
---
http://www.has-sante.fr/portail/jcms/c_2580474/fr/climaston
http://www.has-sante.fr/portail/jcms/c_1753193/fr/climaston
http://www.has-sante.fr/portail/jcms/c_544838/fr/climaston
2015
false
France
French
evaluation of the transparency committee
tablets
progestins
estrogens
administration, oral
insurance, health, reimbursement
drug combinations
dydrogesterone
estradiol
estrogen replacement therapy
osteoporosis, postmenopausal
dydrogesterone and estrogen
dydrogesterone and estrogen
---
http://www.revmed.ch/RMS/2015/RMS-N-475/Docteur-j-ai-chaud-!-Gestion-des-effets-de-la-menopause-chez-les-patientes-atteintes-d-un-cancer-du-sein
2015
false
false
false
Switzerland
French
journal article
breast neoplasms
antineoplastic agents, hormonal
antineoplastic agents, hormonal
hormone antagonists
hormone antagonists
neoplasms, hormone-dependent
hormone antagonists and related agents
premenopause
postmenopause
hot flashes
neoplasm recurrence, local
tamoxifen
tamoxifen
aromatase inhibitors
aromatase inhibitors
medication adherence
estradiol
estradiol
estradiol
Fulvestrant
Fulvestrant
---
http://www.has-sante.fr/portail/jcms/c_2580477/fr/oesclim
http://www.has-sante.fr/portail/jcms/c_1046772/oesclim
2015
false
France
French
postmenopause
estradiol
estrogens
estradiol
insurance, health, reimbursement
estrogen replacement therapy
treatment outcome
estradiol
estrogens
administration, cutaneous
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2058267/fr/oestrogel-oestrodose-thais-thaissept
http://www.has-sante.fr/portail/jcms/c_1753153/fr/oestrogel-oestrodose-thais-thaissept
http://www.has-sante.fr/portail/jcms/c_1046775/oestrogel-oestrodose-thais-thaissept
2015
false
France
French
postmenopause
osteoporotic fractures
treatment outcome
estradiol
insurance, health, reimbursement
estradiol
administration, cutaneous
transdermal patch
gels
estrogens
estrogen replacement therapy
osteoporosis, postmenopausal
risk assessment
estradiol
estrogens
evaluation of the transparency committee
---
https://www.has-sante.fr/portail/jcms/c_2881407/fr/colpotrophine
2014
true
France
French
vulvar diseases
vaginal diseases
atrophy
Vulvovaginal atrophy
promestriene
estradiol congeners
administration, intravaginal
estradiol
promestriene
insurance, health, reimbursement
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1753126/fr/divina-duova
2014
false
France
French
postmenopause
estrogens
divina
drug combinations
administration, oral
medroxyprogesterone and estrogen
medroxyprogesterone and estrogen
medroxyprogesterone acetate
estradiol
hormone replacement therapy
insurance, health, reimbursement
estrogens
progesterone congeners
osteoporosis, postmenopausal
osteoporotic fractures
evaluation of the transparency committee
drug combinations
estradiol
medroxyprogesterone
---
http://www.has-sante.fr/portail/jcms/c_1753196/fr/estraderm-vivelledot
http://www.has-sante.fr/portail/jcms/c_1046793/estraderm-tts-vivelledot
http://www.has-sante.fr/portail/display.jsp?id=c_399598
2014
false
France
French
treatment outcome
postmenopause
evaluation of the transparency committee
administration, cutaneous
estradiol
estrogens
estrogen replacement therapy
insurance, health, reimbursement
osteoporosis, postmenopausal
osteoporotic fractures
estradiol
transdermal patch
---
http://www.has-sante.fr/portail/jcms/c_1753177/fr/oesclim-oromone
2014
false
France
French
administration, oral
osteoporosis, postmenopausal
postmenopause
estradiol
estrogens
estradiol
insurance, health, reimbursement
estrogen replacement therapy
treatment outcome
estradiol
estrogens
administration, cutaneous
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1753135/fr/femseptcombi-femseptevo
http://www.has-sante.fr/portail/display.jsp?id=c_544855
2014
false
France
French
treatment outcome
postmenopause
progesterone congeners
drug combinations
administration, cutaneous
estradiol
estrogens
levonorgestrel
hormone replacement therapy
levonorgestrel and estrogen
levonorgestrel and estrogen
insurance, health, reimbursement
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1753171/fr/provames
http://www.has-sante.fr/portail/jcms/c_1058653/provames
http://www.has-sante.fr/portail/display.jsp?id=c_544883
2014
false
France
French
postmenopause
evaluation of the transparency committee
tablets
administration, oral
estradiol
estrogens
insurance, health, reimbursement
estradiol
estrogen replacement therapy
osteoporosis, postmenopausal
treatment outcome
---
http://www.has-sante.fr/portail/jcms/c_732165/colpotrophine
http://www.has-sante.fr/portail/jcms/c_1738588/fr/colpotrophine
2014
France
French
vulvar diseases
vaginal diseases
atrophy
atrophy of vulva
atrophic vulvovaginitis
promestriene
estradiol congeners
administration, intravaginal
estradiol
promestriene
insurance, health, reimbursement
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1753529/fr/estrapatch
http://www.has-sante.fr/portail/display.jsp?id=c_544965
2014
false
France
French
postmenopause
administration, cutaneous
estradiol
insurance, health, reimbursement
estradiol
estrogens
estrogen replacement therapy
treatment outcome
estradiol
estrogens
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1753129/fr/delidose
http://www.has-sante.fr/portail/jcms/c_900512/delidose
2014
false
France
French
estrogen replacement therapy
treatment outcome
postmenopause
evaluation of the transparency committee
estradiol
administration, cutaneous
estradiol
estrogens
insurance, health, reimbursement
---
http://www.prescrire.org/Fr/3/31/47894/0/2012/ArchiveNewsDetails.aspx
2013
contraceptives, oral
estradiol
nomegestrol
contraception oral
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61335127
2012
France
summary of product characteristics
nomegestrol acetate
nomegestrol acetate
acetates
tablets
estradiol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68208043
2012
France
summary of product characteristics
package leaflet
tablets
estradiol
dydrogesterone
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68119000
2012
France
summary of product characteristics
package leaflet
vaginal creams, foams, and jellies
estradiol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67583656
2012
France
summary of product characteristics
package leaflet
transdermal patch
estradiol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65917954
2012
France
summary of product characteristics
package leaflet
transdermal patch
estradiol
---
https://www.ema.europa.eu/medicines/human/EPAR/Ioa
2012
United Kingdom
French
English
syndication feed
estradiol
nomegestrol acetate
drug combinations
contraceptives, oral, combined
contraceptives, oral, combined
drug approval
treatment outcome
nomegestrol and estradiol
nomegestrol acetate
progesterone congeners
progesterone congeners
estradiol
estrogens
estrogens
drug interactions
pregnancy
breast feeding
megestrol
megestrol
norpregnadienes
norpregnadienes
summary of product characteristics
package leaflet
drug evaluation
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62364911
2012
France
summary of product characteristics
package leaflet
estradiol
transdermal patch
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65268373
2012
France
summary of product characteristics
package leaflet
estradiol
transdermal patch
---
https://www.ema.europa.eu/medicines/human/EPAR/Zoely
2012
United Kingdom
English
French
syndication feed
megestrol
megestrol
norpregnadienes
norpregnadienes
nomegestrol and estradiol
contraceptives, oral, combined
contraceptives, oral, combined
drug approval
treatment outcome
administration, oral
estradiol
nomegestrol acetate
nomegestrol acetate
estradiol
estrogens
estrogens
progestins
progestins
drug combinations
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
---
http://www.has-sante.fr/portail/display.jsp?id=c_544847
http://www.has-sante.fr/portail/jcms/c_1058667/climara
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/climara_-_ct-10529.pdf
2011
France
French
administration, cutaneous
estradiol
estrogens
insurance, health, reimbursement
estradiol
estrogen replacement therapy
osteoporosis, postmenopausal
treatment outcome
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/vagifem_avis1_ct10309.pdf
http://www.has-sante.fr/portail/jcms/c_1097703/vagifem-estradiol-estrogene-synthese-d-avis
2011
France
French
evaluation of the transparency committee
administration, intravaginal
estradiol
estradiol
insurance, health, reimbursement
estrogen replacement therapy
atrophy
vagina
estradiol
estrogens
estrogens
treatment outcome
---
http://www.has-sante.fr/portail/jcms/c_1064173/vagifem
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/vagifem_avis1_ct10309.pdf
2011
France
French
evaluation of the transparency committee
estradiol
administration, intravaginal
estradiol
insurance, health, reimbursement
estrogens
postmenopause
estrogens
estrogen replacement therapy
treatment outcome
estradiol
estrogens
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-04/femsept_femseptcombi_femseptevo_-_ct-10314.pdf
http://www.has-sante.fr/portail/jcms/c_1046823/femsept-femseptcombi-femseptevo
2011
France
French
estradiol
administration, cutaneous
transdermal patch
levonorgestrel and estrogen
hormone replacement therapy
levonorgestrel
drug combinations
levonorgestrel and estrogen
estrogens
estradiol
insurance, health, reimbursement
risk assessment
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_817325/divina-duova
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-07/divina_-_duova_-_ct-6669.pdf
2009
France
French
divina
drug combinations
administration, oral
medroxyprogesterone and estrogen
medroxyprogesterone and estrogen
medroxyprogesterone acetate
estradiol
hormone replacement therapy
insurance, health, reimbursement
estrogens
progesterone congeners
osteoporosis, postmenopausal
fractures, bone
evaluation of the transparency committee
estradiol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65470528
2009
France
French
administration, cutaneous
estradiol
estrogens
estrogen replacement therapy
osteoporosis, postmenopausal
fractures, bone
estradiol
estrogens
gels
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62210849
2009
France
French
administration, oral
hormone replacement therapy
drug combinations
estradiol
estrogens
progesterone congeners
norethisterone and estrogen
estradiol, norethindrone drug combination
norethindrone
tablets
osteoporosis, postmenopausal
fractures, bone
summary of product characteristics
package leaflet
Norethindrone Acetate
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-08/oromone-_ct-6812.pdf
http://www.has-sante.fr/portail/jcms/c_834956/oromone
2009
France
French
administration, oral
estradiol
estrogens
estradiol
insurance, health, reimbursement
estrogen replacement therapy
osteoporosis, postmenopausal
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_901524/dermestril-dermestril-septem
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-01/dermestril_dermestril_septem_-_ct-7312.pdf
2009
France
French
evaluation of the transparency committee
administration, cutaneous
estradiol
estrogens
estradiol
insurance, health, reimbursement
estrogen replacement therapy
postmenopause
transdermal patch
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60940721
2009
France
French
estradiol
tablets
osteoporosis, postmenopausal
fractures, bone
estradiol
estrogens
estrogens
administration, oral
estrogen replacement therapy
package leaflet
summary of product characteristics
estradiol
estradiol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67361246
2009
France
French
estradiol
nandrolone
dienogest
contraceptives, oral
estradiol valerate-dienogest
drug interactions
pregnancy
breast feeding
estrogens
tablets
administration, oral
drug combinations
contraceptives, oral, sequential
progestogens and estrogens, sequential preparations
package leaflet
summary of product characteristics
estradiol
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4446_avadene_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_545506
2007
France
French
tablets
administration, oral
Gestodene
progestins
estradiol
drug combinations
estrogens
progestogens and estrogens, sequential preparations
insurance, health, reimbursement
hormone replacement therapy
osteoporosis, postmenopausal
treatment outcome
norpregnenes
norpregnenes
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_544817
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-2276_estalis_.pdf
2007
France
French
estradiol, norethindrone drug combination
estradiol, norethindrone drug combination
drug combinations
estradiol
norethindrone
administration, cutaneous
insurance, health, reimbursement
norethisterone and estrogen
estrogens
hormone replacement therapy
osteoporosis, postmenopausal
treatment outcome
estradiol
transdermal patch
guidelines for drug use
evaluation of the transparency committee
Norethindrone Acetate
Norethindrone Acetate
---
http://www.has-sante.fr/portail/display.jsp?id=c_544890
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-2913_menorest_.pdf
2007
France
French
administration, cutaneous
estradiol
estrogens
insurance, health, reimbursement
estradiol
estrogen replacement therapy
osteoporosis, postmenopausal
estradiol
estrogens
treatment outcome
guidelines for drug use
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_574365
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4514_climodiene.pdf
2007
France
French
tablets
administration, oral
drug combinations
dienogest
dienogest and estrogen
estrogen replacement therapy
estradiol valerate-dienogest
nandrolone
estrogens
insurance, health, reimbursement
estradiol
evaluation of the transparency committee
estradiol
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4575_diviseq.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_574437
2007
France
French
tablets
drug combinations
medroxyprogesterone acetate
administration, oral
insurance, health, reimbursement
estrogens
medroxyprogesterone and estrogen
estrogen replacement therapy
treatment outcome
estradiol
evaluation of the transparency committee
estradiol
---
http://www.has-sante.fr/portail/display.jsp?id=c_545492
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4423_duova_.pdf
2007
France
French
administration, oral
drug combinations
insurance, health, reimbursement
medroxyprogesterone acetate
estrogens
medroxyprogesterone and estrogen
estradiol
treatment outcome
osteoporosis, postmenopausal
tablets
progesterone congeners
hormone replacement therapy
evaluation of the transparency committee
estradiol
---
http://www.has-sante.fr/portail/display.jsp?id=c_544976
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3734_estreva_.pdf
2007
France
French
gels
tablets
administration, oral
administration, cutaneous
estradiol
estrogens
estrogen replacement therapy
estradiol
insurance, health, reimbursement
osteoporosis, postmenopausal
fractures, bone
evaluation of the transparency committee
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64183183
2007
France
French
estradiol
estrogens
administration, oral
estradiol
estrogen replacement therapy
osteoporosis, postmenopausal
fractures, bone
estradiol
estrogens
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/display.jsp?id=c_544868
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-2807_femsept_.pdf
2007
France
French
administration, cutaneous
insurance, health, reimbursement
estradiol
estradiol
estrogens
estrogen replacement therapy
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032304.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400727
2005
France
French
estradiol
estrogens
insurance, health, reimbursement
estrogen replacement therapy
administration, cutaneous
estradiol
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400304
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031880.pdf
2005
France
French
administration, cutaneous
levonorgestrel and estrogen
levonorgestrel
progesterone congeners
drug combinations
estradiol
estrogens
insurance, health, reimbursement
hormone replacement therapy
treatment outcome
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400708
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032285.pdf
2005
France
French
estrogens
estradiol
administration, cutaneous
estrogen replacement therapy
estradiol
insurance, health, reimbursement
osteoporosis, postmenopausal
fractures, bone
transdermal patch
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/novofemme.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_399506
2002
France
French
tablets
administration, oral
drug combinations
progesterone congeners
norethindrone
estradiol
estrogens
hormone replacement therapy
norethisterone and estrogen
insurance, health, reimbursement
osteoporosis, postmenopausal
fractures, bone
evaluation of the transparency committee
Norethindrone Acetate
---
http://www.has-sante.fr/portail/display.jsp?id=c_399641
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct021197.pdf
2002
France
French
nomegestrol and estrogen
nomegestrol acetate
estradiol
estrogens
insurance, health, reimbursement
hormone replacement therapy
progesterone congeners
megestrol
norpregnadienes
drug combinations
administration, oral
megestrol
norpregnadienes
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_399549
2002
France
evaluation of the transparency committee
equipment and supplies
estradiol
---
http://www.has-sante.fr/portail/display.jsp?id=c_399490
2002
France
evaluation of the transparency committee
transdermal patch
estradiol
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct010341.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_399057
2001
France
French
Trisequens
administration, oral
estradiol
drug combinations
estrogens
norethindrone
progesterone congeners
hormone replacement therapy
osteoporosis, postmenopausal
fractures, bone
insurance, health, reimbursement
norethisterone and estrogen
tablets
evaluation of the transparency committee
Norethindrone Acetate
---
http://www.has-sante.fr/portail/display.jsp?id=c_398979
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct010650.pdf
2001
France
French
tablets
administration, oral
hormone replacement therapy
drug combinations
estradiol
estrogens
progesterone congeners
estradiol, norethindrone drug combination
norethindrone
norethisterone and estrogen
insurance, health, reimbursement
osteoporosis, postmenopausal
evaluation of the transparency committee
Norethindrone Acetate
---
http://www.has-sante.fr/portail/display.jsp?id=c_398934
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct010616.pdf
2001
France
French
evaluation of the transparency committee
levonorgestrel and estrogen
levonorgestrel
drug combinations
estradiol
estrogens
progesterone congeners
administration, cutaneous
insurance, health, reimbursement
hormone replacement therapy
transdermal patch
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct010104.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_398903
2001
France
French
administration, cutaneous
estradiol
estradiol
estrogens
insurance, health, reimbursement
osteoporosis, postmenopausal
fractures, bone
gels
evaluation of the transparency committee
---
